Published in Scand J Occup Ther on November 25, 2010
Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. Arch Gen Psychiatry (2008) 1.64
Neuroimaging in social anxiety disorder: a systematic review of the literature. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.55
Psychometric properties of the Fagerström Test for Nicotine Dependence. J Bras Pneumol (2009) 1.46
Functional neuroimaging of minocycline's effect in a patient with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.43
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology (2011) 1.41
Duloxetine in the treatment of social anxiety disorder. J Clin Psychopharmacol (2007) 1.40
Study of the discriminative validity of the PHQ-9 and PHQ-2 in a sample of Brazilian women in the context of primary health care. Perspect Psychiatr Care (2009) 1.24
Is the full version of the AUDIT really necessary? Study of the validity and internal construct of its abbreviated versions. Alcohol Clin Exp Res (2010) 1.24
Comparability between telephone and face-to-face structured clinical interview for DSM-IV in assessing social anxiety disorder. Perspect Psychiatr Care (2008) 1.21
[Factorial structure of the Brazilian version of the Modified Reasons for Smoking Scale]. Rev Assoc Med Bras (2009) 1.08
Cannabidiol monotherapy for treatment-resistant schizophrenia. J Psychopharmacol (2006) 1.08
Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf (2011) 1.03
Altered gray matter morphometry and resting-state functional and structural connectivity in social anxiety disorder. Brain Res (2011) 1.03
Adhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry (2011) 1.03
The psychiatric side-effects of rimonabant. Rev Bras Psiquiatr (2009) 1.02
[Therapeutical use of the cannabinoids in psychiatry]. Rev Bras Psiquiatr (2010) 0.98
Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion. Hum Brain Mapp (2011) 0.97
A study of the discriminative validity of a screening tool (MINI-SPIN) for social anxiety disorder applied to Brazilian university students. Eur Psychiatry (2007) 0.96
Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder. Neurosci Lett (2006) 0.96
Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis. Schizophr Res (2010) 0.94
Structural magnetic resonance imaging in anxiety disorders: an update of research findings. Rev Bras Psiquiatr (2008) 0.92
National Science and Technology Institute for Translational Medicine (INCT-TM): advancing the field of translational medicine and mental health. Rev Bras Psiquiatr (2010) 0.91
Interaction between cannabidiol (CBD) and ∆(9)-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids. Psychopharmacology (Berl) (2011) 0.90
Psychometric qualities of the Brazilian versions of the Fagerström Test for Nicotine Dependence and the Heaviness of Smoking Index. Nicotine Tob Res (2009) 0.90
Neuroimaging in specific phobia disorder: a systematic review of the literature. Rev Bras Psiquiatr (2012) 0.89
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation. Curr Pharm Des (2012) 0.89
Social anxiety disorder women easily recognize fearfull, sad and happy faces: the influence of gender. J Psychiatr Res (2009) 0.89
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug. Rev Bras Psiquiatr (2012) 0.89
Evaluation of the psychometric properties of the Social Phobia Inventory in university students. Compr Psychiatry (2010) 0.88
Social phobia in Brazilian university students: prevalence, under-recognition and academic impairment in women. J Affect Disord (2011) 0.86
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study. J Clin Psychopharmacol (2016) 0.86
The accuracy of diagnosis of major depression in patients with Parkinson's disease: a comparative study among the UPDRS, the geriatric depression scale and the Beck depression inventory. Arq Neuropsiquiatr (2008) 0.85
Do psychiatric comorbidities predict postoperative seizure outcome in temporal lobe epilepsy surgery? Epilepsy Behav (2009) 0.85
Validity of the PHQ-2 for the screening of major depression in Parkinson's disease: two questions and one important answer. Aging Ment Health (2011) 0.85
Oxytocin interference in the effects induced by inhalation of 7.5% CO(2) in healthy volunteers. Hum Psychopharmacol (2012) 0.84
Further study of the psychometric qualities of a brief screening tool for social phobia (MINI-SPIN) applied to clinical and nonclinical samples. Perspect Psychiatr Care (2010) 0.83
[Guidelines of the Brazilian Medical Association for the diagnosis and differential diagnosis of social anxiety disorder]. Rev Bras Psiquiatr (2010) 0.83
Further psychometric study of the Beck Anxiety Inventory including factorial analysis and social anxiety disorder screening. Int J Psychiatry Clin Pract (2011) 0.82
Cross- cultural validation of the Brazilian Portuguese version of the Social Phobia Inventory (SPIN): study of the items and internal consistency. Rev Bras Psiquiatr (2008) 0.82
Electroconvulsive therapy for coexistent schizophrenia and obsessive-compulsive disorder. J Clin Psychiatry (2005) 0.82
Are there differences between early- and late-onset social anxiety disorder? Rev Bras Psiquiatr (2007) 0.82
Psychometric validation study of the liebowitz social anxiety scale - self-reported version for Brazilian Portuguese. PLoS One (2013) 0.81
The fast alcohol screening test (FAST) is as good as the AUDIT to screen alcohol use disorders. Subst Use Misuse (2010) 0.81
Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD). Rev Bras Psiquiatr (2010) 0.80
Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: a systematic review. ASN Neuro (2014) 0.80
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychopharmacol (2009) 0.80
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report. Hum Psychopharmacol (2013) 0.80
Cross-cultural validation of the Brief Social Phobia Scale for use in Portuguese and the development of a structured interview guide. Rev Bras Psiquiatr (2006) 0.80
Anxiety and joint hypermobility association: a systematic review. Rev Bras Psiquiatr (2012) 0.80
Gender differences and the effects of ketamine in healthy volunteers. J Psychopharmacol (2004) 0.79
Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm. Neuropsychopharmacology (2011) 0.79
Psychometrics properties of early trauma inventory self report - short form (ETISR-SR) for the Brazilian context. PLoS One (2013) 0.79
Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins. Mol Neurobiol (2014) 0.79
Agomelatine in the treatment of social anxiety disorder. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.79
[Cannabis sativa: the plant that can induce unwanted effects and also treat them]. Rev Bras Psiquiatr (2010) 0.78
Why should Cannabis be Considered Doping in Sports? Front Psychiatry (2013) 0.78
Marijuana, feijoada and the debate on drug legalization. Front Psychiatry (2013) 0.78
Interictal SPECT in patients with mesial temporal lobe epilepsy and psychosis: a case-control study. Psychiatry Res (2005) 0.78
Disability profile/clinician-rated: validity for Brazilian university students with social anxiety disorder. Span J Psychol (2013) 0.78
A motivational profile for smoking among adolescents. J Addict Med (2013) 0.78
Validity of a Brazilian version of the Zung self-rating depression scale for screening of depression in patients with Parkinson's disease. Parkinsonism Relat Disord (2009) 0.77
Adaptation and initial psychometric study of the self-report version of Liebowitz Social Anxiety Scale (LSAS-SR). Int J Psychiatry Clin Pract (2012) 0.77
Social anxiety and negative early life events in university students. Rev Bras Psiquiatr (2012) 0.77
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats. J Psychopharmacol (2013) 0.77
Cannabis use, cognition and brain structure in first-episode psychosis. Schizophr Res (2013) 0.77
The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia: a pilot study. J Clin Psychopharmacol (2015) 0.77
Duloxetine in the treatment of panic disorder. Int J Neuropsychopharmacol (2005) 0.77
Is the Fagerström Test for Nicotine Dependence a good instrument to assess tobacco use in patients with schizophrenia? Rev Bras Psiquiatr (2009) 0.77
Nitric oxide plasma/serum levels in patients with schizophrenia: a systematic review and meta-analysis. Rev Bras Psiquiatr (2012) 0.77
Late-onset social anxiety disorder following traumatic brain injury. Brain Inj (2012) 0.77
Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection. Mol Neurobiol (2013) 0.76